What's New in Data Updates

Bp Premier data updates are available for download from the Best Practice Software Resources page.

May 2021

Release date: 06 May 2021

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1–2, Jade, Jade SP1–4, Saffron.

Templates

MBS Update

No May update.

DVA Update

DVA Fees updated as per March released fees.

Other items

• Added monitored drugs for SA
• Updated Workcover certificates (QLD sites only)

Application roles

• Cartula Health was added
• Sonic Bridge was added
• Medi2Apps was updated.

Conditions added

• Mole mapping
• Emgality injection
• Galcanezumab injection
• High tibial osteotomy (HTO)
• Plasmacytoma
• Epigastric hernia repair
• Hernia repair, epigastric
• Repair of epigastric hernia
• Drainage of felon
• Lobectomy, Temporal
• Excision of temporal lobe
• Referral to colorectal surgeon
• Colorectal surgeon referral
• Carer Support
• Liaison
• Continence referral
• Referral, continence
• Referral to continence nurse
• Visually-induced vertigo
• Psychogenic vertigo
• Kyleena insertion
• Insertion of Kyleena
• Hallux valgus repair
• Repair of hallux valgus
• Malakoplakia of bladder
• Reactive hypoglycaemia
• Hypoglycaemic reaction
• Insulin resistance
• Vaginal wall prolapse repair
• Repair of vaginal wall prolapse
• Colporrhaphy
• Atrial flutter ablation

Medications

• Little Green Pharma MC product added
• Dexamphetamine spelling now correct when selecting drug to prescribe
• MedReleaf products added
• Add Immunisation "Shingrix"
• Asacol Tablets 1.6mg
• CanniMed Oil 18:1
• CDA products (Oil, powder, capsules, lozenges)
• Epidyolex oral solution 100mg
• Ferropods capsules
• Kesimpta solution for injection 20mg
• Restoricann 20:1 THC/CBD Sativa Oil
• Spectrum Therapeutics Cannabis Oil
• Spravato nasal spray 28mg
• Trikafta tablets composite pack
• ViruPOS eye ointment 3%

April 2021

Release date: 07 April 2021

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1–2, Jade, Jade SP1–4, Saffron.

Templates

Other items

Application roles

• OzBiz Solutions was removed.

Conditions added

• COVID-19 Vaccination dose 1
• Immunisation, COVID-19 dose 1
• COVID-19 Vaccination, dose 2
• Immunisation, COVID-19 dose 2
• COVID-19 vaccine suitability assessment
• Ferritin level low
• Home Medicine Review
• HMR
• HMR organised
• HMR consent/paperwork

Medications

• Updated Ketamine and Ketalar to Schedule 8
• Ability to print brand name and allow brand substitution for Valpro and equiv products
• Insulin Glulisine appears as per PBS listing
• Alternate brands available for Levothyroxine and strengths now consistent
• Swisse Nutra+ products
• Biostime products
• Orgalutran 250mcg/0.5mL Syringe printing with active ingredient
• Aleve 24 Hour Sustained release tablets
• Axotide inhaler 50mcg & 100mcg
• Cosentyx 150mg
• COVID-19 Vaccine AstraZeneca Solution for injection
• Dulcosoft 10mg
• Dupixent 200mg & 300mg
• Enerzair Breezhaler
• Evenity 105mg
• Frusemix-M / Lasix / Urex / Urex-M / Urex Forte 20mg
• Fycompa 2mg
• Adalimumab - prefilled pen, prefilled syringe – 20mg, 40mg & 80mg
• Medcan products
• MOCA products
• Movapo 20mg & 50mg
• OxyNorm 5mg
• QV Dermcare products
• ViruPOS 3%

MBS Update

Extension of telehealth and telephone services until 30 June 2021 . See the MBS announcement here.

March 2021

Release date: 05 March 2021

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1–2, Jade, Jade SP1–4, Saffron.

Templates

Other items

Application roles

• Healthsite – added permissions
• Medlink Connect - updated

Medications: Active ingredient prescribing issues addressed

• Tramal SR 100 100mg Slow Release now prints active ingredients
• Flixotide Accuhaler no longer includes lactose as active ingredient
• Advantan now prints with form on script (ie Fatty Ointment)
• Bimatoprost Eye Drops now prompts for LMBC
• Novomix 30 now shows the active ingredient protamine when printed
• Actonel EC tablets now show Risedroante Enteric coating when printed
• Ventolin CFC-Free now prints the active ingredients Salbutamol Sulfate
• Seroquel now correctly prints as Quetiapine extended release
• Resprim Forte now prints the strength (mg) for active ingredients correctly
• Estalis Patch now prints with active ingredients (all variants)

Medications: other changes

• Fucidin Ointment 15g added
• MediCabilis products added
• LGP Classic Medicinal Cannabis product added
• Multi-Action eye spray added
• Panadeine removed

MBS updates

The MBS update for March 2021 includes minor policy changes which were recommended by the clinician-led MBS Review Taskforce or the Medicare Benefits Schedule Committee and also incorporates eight legislative instruments which are made under subsection 3C(1) of the Health Insurance Act 1973.

More information on these changes is available on the March 2021 news page at http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/news-210301.

This update also includes COVID-19 Vaccination items.

The Australian Government is committed to offering every person in Australia access to safe and effective COVID-19 vaccines at no cost. From March 2021, 16 new MBS items will be available to enable GPs and suitably qualified health professionals to assess patients for their suitability to receive a COVID-19 vaccine. The MBS COVID-19 vaccine suitability assessment service is free to Medicare eligible patients and the MBS items must be bulk billed.

The MBS items are part of the Australian Government’s second phase of the COVID-19 vaccination program (known as phase 1B). Under this phase, the Government will work with accredited general practices, General Practitioner-led Respiratory Clinics and Aboriginal Community Controlled Health Services to vaccinate certain cohorts of persons aged 18 years of age or older. Accredited general practices will be supplied the AstraZeneca COVID-19 vaccine to commence vaccinating priority population groups, including persons 70 years of age or older, other health care workers, Aboriginal and Torres Strait Islanders 55 years or older, persons with an underlying medical condition, and critical and high risk workers.

General practice will also be involved in latter phases of the vaccination program which aims to vaccinate all Medicare-eligible persons aged 18 years of age and older. The majority of patients are expected to receive the vaccine twice.

For more information go to http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/news-210301a

February 2021

Release date: 08 February 2021

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1–2, Jade, Jade SP1–4, Saffron.

Templates

Conditions added

• Vitamin C infusion
• Hearing loss, asymmetrical
• Asymmetrical hearing loss
• Removal of antrochoanal polyp
• Removal of stent
• Rotator cuff injury
• Rotator cuff disorder
• Removal of sarcoma tumour
• Short leg
• Tear duct obstructed
• Tendinopathy
• Knee joint valgus deformity

Medications: added or updated

• When prescribing and printing Evelyn or Lebnest active ingredient Ethinyloestradiol now prints on the script.
• Prescribing Neupro at any mg is now printing out as Rotigotine at correct strength
• When prescribing Rotigotine correct strength is now printed on script
• Prescribing Esomeprazole HP7 now prints all active ingredients on script
• Prescribing Adacel Vial now shows Adacel on printed script
• Ventolin CFC-Free 100mcg/dose Inhaler now printing with active ingredient Salbutamol Sulfate
• Avara Combination pack now prints details of the pack on script
• Ivabradine now prints out correct strength on script
• Updated Spectrum MC products
• Updated Cannatrek MC products
• Add Circle CBD Pure 100 Oil drops
• Add Circle Balance 10
• Lenest 30mg/150mg now printing correctly

Application roles

• Weelio
• Manage My Health
• Health Engine (updated)
• Cubiko (updated)

Other items

• Removed FHIR access for Telstra user

January 2021 Revision 1

Release date: 20 January 2021

Applies to: Bp Premier Saffron only. Users running Jade who have not yet upgraded to version Saffron do not need to run this update.

January 2021

Release date: 05 January 20201

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1, Indigo SP2, Jade, Jade SP1, Jade SP2, Jade SP3, Jade SP4, Saffron.

Certificates

MBS Update

• December 24 2020 - This includes additional MBS items for care recipients in residential aged care facilities. More information on this change is available on the December News page.
• January 01, 2020 - This includes the annual indexation of the EMSN and minor descriptor changes for items 39018 39109 39113 73337. More information on this change is available on the January 2021 News page.
• Ceased items as of November 2020 which were available to bill have now been updated. See this link for more information.

Other items

• Murtagh Patient Education Material updated for Vertigo and Vitiligo
• Update Copyright info of Help > About
• Updated Sonic Test list

Application roles

• Fixed collation issue with BP_RevokeInvalidAppRolePermissions
• MyHealth1st application role (MH1) now has access to the CancelledAppointments table (minus Reason column)
• Updated deployment of app role permissions
• Amended heart failure warning for Trulicity so it is equitable with Ozempic

Conditions added

• Desmoid tumour
• Fibromatosis, aggressive
• Middle ear, suction clearance
• External auditory canal, suction clearance
• Focused psychological strategies
• Fibreglass cast, applied
• Fibreglass cast, removed
• Fibreglass cast, problem with
• Vulval discomfort
• Gastric sleeve surgery
• Pancreatic insufficiency
• Statin induced myopathy
• Myopathy due to statin
• Statin induced myalgia
• Myalgia due to statin
• Finger ulcer
• Sebastian platelet syndrome
• Catatonia
• Patent foramen ovale, closure
• Blood glucose level
• BGL
• Fasting blood glucose level, raised
• Spinocerebellar Ataxia, Type 1
• Spinocerebellar Ataxia, Type 2
• Spinocerebellar Ataxia, Type 6
• Spinocerebellar Ataxia, Type 7
• Pyroluria
• Mast cell activation syndrome
• AIR check
• Australian immunisation register check
• Cauterisation
• Clinical image added
• Correspondence added
• Curettage and cauterisation of skin lesion
• Total hip resurfacing arthroplasty
• Resurfacing hip prosthesis
• Medial collateral ligament of knee sprain
• Haemorrhagic cystitis
• Infected umbilical granuloma
• Umbilical infection of newborn
• Emotional dysregulation
• Eyelid cyst
• Eyelid cyst, lower lid
• Eyelid cyst, upper lid
• Left ventricular thrombus
• Optometry service
• Parainfluenza
• Atrial fibrillation ablation
• Aortic root replacement
• Macrodactyly
• Serrated polyposis syndrome
• Acute kidney injury
• Metatarsophalangeal joint capsule of great toe
• Bladder pain syndrome
• Excision of bulla of lung
• Deflation of bulla of lung

Medications: added or updated

• Apomine products
• Cablivi powder for injection 10mg
• Difflam Plus Dry Cough Relief Sore Throat Lozenges
• Laxettes with Sennosides chocolate squares
• Otezla tablets 30mg & Titration pack
• Slenyto tablets 1mg & 5mg
• Strepsils Sugar-Free lozenges
• Tagrisso tablets 40mg & 80mg
• Atorvachol tablets 80mg
• Carvidol tablets
• Pulmoris tablets 5 & 10mg
• Prozac dispersible tablets 20mg

Medications: removed

• Calcipotriol

December 2020 Revision 1

Release date: 18 December 2020

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1, Indigo SP2, Jade, Jade SP1, Jade SP2, Jade SP3, Jade SP4, Saffron.

Certificates

MBS Update

From 10 December 2020 until 30 June 2022, new Medicare Benefits Schedule (MBS) items will be available for care recipients in residential aged care facilities, which supports the mental and physical health of aged care residents who have been affected by the COVID-19 pandemic or the measures taken to contain its spread.

There will be an additional 73 temporary items to allow care recipients of a residential aged care facility to increase the amount of selected Medicare subsidised chronic disease management plan allied health services, and enable residential care recipients to access allied health group services.

The new MBS items for care recipients in a residential aged care facility replicate the existing face-to-face and telehealth items for:

• allied health chronic disease management plan services
• indigenous follow up services for eligible patients who have received a health assessment
• group assessment services.

There will also be new temporary residential aged care facility MBS items that permit residential care recipients to access up to 10 services per calendar year for selected physical therapy services, including exercise physiology, occupational therapy and physiotherapy.

In addition, new temporary face-to-face MBS items will be introduced for care recipients of a residential aged care facility for longer initial individual allied health chronic disease management services and initial Indigenous follow up services.

There will also be an additional 50 new items for the creation and review of a mental health treatment plan specific to care recipients of residential aged care facilities. These changes will provide access for care recipients in residential aged care facilities with access to the existing individual mental health treatment services and where necessary provide residential care recipients with access to the additional 10 individual treatment services that were introduced in August 2020.

Conditions

• Referral to exercise physiologist (RFV) added

Medications: added or updated

• Palexia - generic listing for 50mg updated to show SR

December 2020

Release date: 09 December 2020

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1, Indigo SP2, Jade, Jade SP1, Jade SP2, Jade SP3, Jade SP4, Saffron.

Update for Queensland WorkCover

After you run the December 2020 Data Update, if you have a requirement to claim through Queensland WorkCover and have not previously contacted Best Practice Support to manually rectify this issue, follow the instructions below on each workstation used for processing Queensland WorkCover claims.

From the main screen of Bp Premier:

1. Select Setup > Configuration.
2. Select the WorkCover tab from the Configuration screen.
3. Click Setup.
4. Click Install Certificates.
5. When presented with a prompt advising 'QLD WorkCover certificates already appear to be installed, do you want to reinstall them?', click Yes.

Templates

The following word processor template changes have been made:

Reports

Other

Third-party database access

MBS

From 1 December 2020, amendments to MBS item 18361 for the treatment of moderate to severe upper limb spasticity due to cerebral palsy will enable Medicare benefits to be paid for injection of the patients who meet the same criteria as the Pharmaceutical Benefits Schedule (PBS) listed medicines.

The changes to item 18361 will include adding Clostridium Botulinum Type A Toxin-Haemagglutinin Complex (Dysport®) as an acceptable alternative treatment, and a patient who is at least 18 years of age no longer has to have commenced treatment for the spasticity with botulinum toxin supplied under the PBS, as is currently outlined in part (b) of the existing MBS descriptor.

DVA Update

Nil

Conditions

Nil

Medications: added or updated

• Adaya CBD 100
• Adaya 1:25 (THC:CBD)
• Adaya 10:10 (THC:CBD)
• Adaya 20:1 (THC:CBD)
• Adaya THC 26
• Althea CBD100
• Althea Rideau CBD25: THC2
• Althea Jasper CBD10: THC5
• Althea Capilano CBD12:THC10
• Althea Champlain THC20: CBD1
• Althea Henik THC18
• Cannatrek T20 Flower (Relax Daylesford)
• Cannatrek T18 Flower (Uplift Lemnos)
• Cannatrek T25 Ruby Oil
• Defitelio concentrated solution for infusion 200mg
• Exufiber dressing
• Flucelvax Quad suspension for injection 60mcg
• Fostair metered dose inhaler
• Frusemix tablets 40mg
• Frusemix-M tablets 20mg
• Gold Cross Methyl Salicylate Products cream
• Gold Cross Pholcodine Linctus APF linctus 1mg
• Infloran capsules
• Inza tablets 500mg
• Little Green Pharma Classic Oil
• Little Green Pharma Classic CBD 50 Oil
• Mag Duo oral powder 337.7mg
• Mepilex Border Flex dressing
• Mepilex Border Heel dressing
• Mepilex Border Sacrum dressing
• Mepitel One nonadherent dressing
• Mutaflor capsules 250million
• Otrivin Clear Seawater & Eucalyptus nasal spray 20mL
• Otrivin Natural Seawater & Eucalyptus nasal spray
• Pirmella 1/35 tablets
• Renastep oral liquid
• Spectrum Blue Softgel Capsules Bottle containing 60 capsules of CBD 3.75mg : THC 2.5mg
• Tilray Full Spectrum Whole Flower THC17 Whole Flower
• Tilray Purified CBD100 Oral solution
• Vyndamax capsules 61mg
• Yomogi capsules 250million

Medications: removed

• ADALAT OROS nifedipine 20 mg tablet blister pack
• ADALAT OROS 60 nifedipine 60 mg modified release tablet blister pack
• ADEFIN 10 nifedipine 10 mg tablet blister pack
• ADALAT OROS 30 nifedipine 30 mg modified release tablet blister pack
• Nifedipine 10mg
• Nifedipine 20mg

November 2020

Release date: 03 November 2020

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1, Indigo SP2, Jade, Jade SP1, Jade SP2, Jade SP3, Saffron.

Templates

The following word processor template changes have been made:

Reports

Nil.

Other

Third-party database access

MBS update

Includes Revised November update.

This includes new, amended, and ceased items.

DVA update

Nil.

Conditions added

Nil.

Medications: added or updated

• Caltrate Bone & Muscle 50+ Years Tablets
• Clavam 875mg/125mg Tablets
• Cyprostat 50 mg Tablets
• Dibenzyline 10mg Capsules
• Dotarem Solution for injection
• Finasta 1 mg & 5 mg Tablets
• Flucloxacillin 250 mg & 500 mg Capsules
• Hycamtin 4mg Powder for infusion
• Lacteeze Chewable tablets
• Lacteeze Infant Drops Oral drops
• Lycinate 600mcg Tablets
• Lynparza 100mg & 150mg Tablets
• Mayzent 250mcg Tablets
• Modafin 100mg Tablets
• Modavigil 100mg Tablets
• Movicol Junior Lemon-Lime Powder for oral solution
• Myocrisin 10mf, 20mg, 50mg Solution for injection
• Neulactil 2.5mg & 10mg Tablets
• Noralin Solution for intravenous infusion
• Phenelzine Sulfate USP 15 mg Tablets
• Prezista 150mg Tablets
• Restylane Defyne Injectable gel
• Restylane Kysse Injectable gel
• Restylane Lyps Lidocaine Injectable gel
• Restylane Refyne Injectable gel
• Restylane Volyme Injectable gel
• Sovaldi 400mg Tablets
• TYR Tylactin Build 20 Powder for oral solution
• Uvadex 20mcg/ml Concentrated injection.

October 2020 Revision 1

IMPORTANT

This Data Update Revision will need to be run outside of business hours. The Data Update Revision makes changes to the database, and if run during business hours may result in errors.

No users or applications should be accessing the system whilst this update is run.

Reports

Sunsetting of Old Reports – users who attempt to run these reports will be presented with a message to inform them. The message will only appear on the financial reports. Ensure that permissions to new reports for users are enabled asap. Old reports were removed September 2020.

Please follow this link to watch our Be In The Know session on this topic

Please follow this link to review our Knowledge base documentation on Switching from old to new reports

Other

• Incentives – we have updated the process so that sites should not see the incentive line item come up with a $0 value.
• Issue where the update would fail and cause issues with 3rd party integrations has been resolved.

MBS Update

Includes updates for applicable from 9 October 2020 – see http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/news-201001

From 9 October 2020, the 36 temporary MBS items that were introduced on 7 August 2020 will be amended to allow any Medicare-eligible person to access up to 10 additional treatment services in a calendar year for treatment of a mental health disorder (additional Better Access treatment services).

This includes new, amended, and ceased items.

DVA Update

Includes updates to fees applicable from 1 October 2020 – specifically incentive items. See

https://www.dva.gov.au/sites/default/files/files/providers/feesschedules/20201001dva-medical-services-schedules_final.pdf

September 2020 Revision 2

• Includes the MBS update as at 15th September.
• Includes a correction to the pack size for Prodeine 15.

September 2020 Revision 1

Some practices with third-party integrations with the Bp Premier database may have experienced issues with their integration after running the September 20 data update. This revision fixes those issues.

September 2020

The description for the September 2020 update now includes changes to reports in this data update.

Release date: 02 September 2020

Applies to: Bp Premier Indigo, Indigo Rev1, Indigo SP1, Indigo SP2, Jade, Jade SP1, Jade SP2, Jade SP3, Saffron.

Templates

The following word processor template changes have been made:

Reports

Updated reports

• Banking (Grouped by Provider) and Banking (Grouped by Provider) by Payment Created now have standardised grouping for both reports.
• Banking (Grouped by Date) by Payment Created Date has had level 4 headings updated to show Payment Run No for Medicare/DVA.
• Banking (Grouped by Date) and Banking (Grouped by Date) by Payment Created Date now have standardised grouping for both reports.
• Banking (Grouped by Bank Account) and Banking (Grouped by Bank Account) by Payment Created Date now have standardised grouping for both reports.
• Banking Summary grouping and sorting now matches the detailed reports for level 1 and level 4 groups.
• Tyro Bulk Bill Easyclaims – Paid Services by Payment Run Number now shows the correct information.
• Referrals – Incoming by Patient / Provider / Status now show item numbers if the service created date is outside of the date range.

New reports

• Work Done and Fees Taken by Provider is a new report equivalent to the old report Work Done by Doctor, Day.
• Item Number Summary by Location

Other

Third-party database access

MBS update

Nil.

DVA update

Conditions added

Medications: added or updated

• Calquence capsules
• Dexmedetomidine Concentrate for infusion 200mcg, 400mcg & 1000mcg
• DuoDERM Extra Thin CGF Dressing – Hydrocolloid Dressing Thin
• DuoDERM Signal - Hydrocolloid Dressing
• Imipramine Hydrochloride Tablets tablets 25mg
• Kozenis tablets 150mg
• Ritalin 10 long acting capsules 60mg
• Cefazolin 2g injection
• Ceftriaxone 1g injection